Art Krieg moves from CEO post to CSO at Check­mate; In­di­v­ior breathes sigh of re­lief af­ter court rul­ing

7 years ago
News Briefing

Up­start Akero con­tin­ues its swoosh in­to NASH space with $70M wind­fall round

7 years ago
Financing

Mallinck­rodt's woes per­sist as re­for­mu­lat­ed opi­oid painkiller fails to pass FDA muster

7 years ago
R&D

Shinichi Tamu­ra re­claims the helm at So­sei as CEO Pe­ter Bains hits the ex­it

7 years ago
People

In a re­peat set­back, Neu­ro­crine flags a fail­ure for Tourette syn­drome study — shares sink

7 years ago
R&D

J&J beats No­var­tis' block­buster ri­val in a head-to-head show­down over the pso­ri­a­sis mar­ket

7 years ago
R&D

Bausch is keen on Syn­er­gy, af­ter trou­bled con­sti­pa­tion drug mak­er files for Chap­ter 11

7 years ago
Pharma

FDA rolls out ex­pec­ta­tions for a loom­ing reg­u­la­to­ry shift for in­sulin and oth­er bi­o­log­ics

7 years ago
Pharma

Eli Lil­ly is go­ing for it again, ink­ing $2B Alzheimer's deal for tau ther­a­pies with AC Im­mune

7 years ago
Pharma

Am­gen en­lists En­tera in a drug dis­cov­ery pact; Boehringer brings out the bud­get ax

7 years ago
News Briefing

Large coali­tion joins drug lob­by in de­nounc­ing Trump pro­pos­al to im­port drug prices for Medicare

7 years ago
Pharma

Clive Mean­well gives way to new CEO as ac­tivist in­vestor Alex Den­ner shakes up The Med­i­cines Com­pa­ny

7 years ago
People

Fresh­man law­mak­ers give J&J CEO Alex Gorsky an­oth­er un­want­ed turn in the pub­lic spot­light

7 years ago
Bioregnum
Opinion

Black Di­a­mond turns down an open stretch of R&D high­way, head­ed to a show­down with onco­genes

7 years ago
Financing
Startups

Tar­get­ing CD47? UCLA joins band­wag­on, with gel to stem tu­mors from resur­fac­ing

7 years ago
Discovery

Too much suc­cess? A boom­ing biotech pipeline will spur in­tense ri­val­ries — an­a­lyst

7 years ago
R&D
Pharma

Sue Dil­lon, Karyn O'Neil steer fledg­ling Aro Bio­ther­a­peu­tics to $13M de­but — with J&J's bless­ing

7 years ago
Financing
Startups

Shang­hai Jun­shi Bio­sciences next to test HKEX list­ing; With one eye on Sage, Mar­i­nus re­ports pre­lim PPD da­ta

7 years ago
News Briefing

WuXi AppTec starts a glob­al wave of ex­pan­sion, jump­ing off in San Diego fol­low­ing $1B Hong Kong IPO raise

7 years ago
Financing

Nas­daq cel­e­brates epic biotech IPO suc­cess in 2018. But can the par­ty on Wall Street rum­ba on?

7 years ago
Financing

As­traZeneca, Can­cer Re­search UK set up ge­nomics hub to fight up­hill bat­tle against can­cer

7 years ago
R&D
Discovery

0-for-2: An­oth­er fad­ed drug star in Ax­o­van­t's much-hyped pipeline falls, tar­nish­ing Ra­maswamy's deal-mak­ing rep

7 years ago
R&D

FDA slaps par­tial hold on Macro­Gen­ics for bis­pe­cif­ic can­cer tri­als as liv­er tox spurs safe­ty fears

7 years ago
R&D

Gilead locks in Daniel O'­Day as CEO, tap­ping the Roche vet to re­ju­ve­nate growth

7 years ago
People
First page Previous page 989990991992993994995 Next page Last page
A service from the Financial Times